Literature DB >> 24274479

Polysaccharide isolated from Agardhiella ramosissima: chemical structure and anti-inflammation activity.

Jalles A Batista1, Eulina G N Dias, Tarcisio V Brito, Rafael S Prudêncio, Renan O Silva, Ronaldo A Ribeiro, Marcellus Henrique L P Souza, Regina C M de Paula, Judith P A Feitosa, Luciano S Chaves, Márcia R S Melo, Ana L P Freitas, Jand-Venes R Medeiros, André L R Barbosa.   

Abstract

The sulfated polysaccharide (PLS) fraction of Agardhiella ramosissima was characterized by microanalysis, infrared spectroscopy, NMR and gas-liquid-chromatography-mass-spectrometry. The main constituent of PLS was the ι carrageenan. The monosaccharide composition of the PLS showed galactose, 3,6-anhydrogalactose and 6-O-methylgalactose. The PLS (30 mg kg(-1)) significantly reduced the paw oedema induced by carrageenan, dextran, histamine and serotonin and also was able to significantly inhibit leucocyte migration into the peritoneal cavity and decrease the concentration of myeloperoxidase (MPO) in paw tissue. In the antinociceptive tests, the pre-treatment with PLS reduced the number of writhes, the licking time but did not increase the latency time of response. This study demonstrates for the first time the anti-inflammatory and anti-nociceptive effects of PLS from A. ramosissima. Thus, we concluded that PLS could be a new natural tool in pain and acute inflammatory conditions.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Agardhiella ramosissima; Anti-inflammatory effect; Antinociceptive action; Chemical structure; Polysaccharide

Mesh:

Substances:

Year:  2013        PMID: 24274479     DOI: 10.1016/j.carbpol.2013.08.071

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  7 in total

1.  Non-clinical safety evaluation of intranasal iota-carrageenan.

Authors:  Alexandra Hebar; Christiane Koller; Jan-Marcus Seifert; Monika Chabicovsky; Angelika Bodenteich; Andreas Bernkop-Schnürch; Andreas Grassauer; Eva Prieschl-Grassauer
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

2.  Inhibition of lipopolysaccharide (LPS)-induced neuroinflammatory response by polysaccharide fractions of Khaya grandifoliola (C.D.C.) stem bark, Cryptolepis sanguinolenta (Lindl.) Schltr and Cymbopogon citratus Stapf leaves in raw 264.7 macrophages and U87 glioblastoma cells.

Authors:  Francine Kengne Mediesse; Thaddée Boudjeko; Anantharaju Hasitha; Matharasala Gangadhar; Wilfred Fon Mbacham; Perumal Yogeeswari
Journal:  BMC Complement Altern Med       Date:  2018-03-12       Impact factor: 3.659

3.  A Novel Polysaccharide Conjugate from Bullacta exarata Induces G1-Phase Arrest and Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells.

Authors:  Ningbo Liao; Liang Sun; Jiang Chen; Jianjun Zhong; Yanjun Zhang; Ronghua Zhang
Journal:  Molecules       Date:  2017-03-01       Impact factor: 4.411

4.  A bioinformatics investigation into the pharmacological mechanisms of the effect of Fufang Danshen on pain based on methodologies of network pharmacology.

Authors:  Yantao Sun; Jie Yang
Journal:  Sci Rep       Date:  2019-04-11       Impact factor: 4.379

Review 5.  Possible Epigenetic Role of Vitexin in Regulating Neuroinflammation in Alzheimer's Disease.

Authors:  M A F Yahaya; S Z I Zolkiffly; M A M Moklas; H Abdul Hamid; J Stanslas; M Zainol; M Z Mehat
Journal:  J Immunol Res       Date:  2020-03-09       Impact factor: 4.818

6.  Clusters of Responders and Predictive Factors for Response to Supplementation with Boswellia, Turmeric, and Red Algae Extracts in Painful Knee Osteoarthritis: A Prospective Observational Study Using an Arsenal of Patient-Centered Measures.

Authors:  Samira Ait Abdellah; Caroline Gal; Anne Leblanc; Anne-Priscille Trouvin; Serge Perrot
Journal:  Open Access Rheumatol       Date:  2021-01-08

7.  A water-soluble polysaccharide from Grifola frondosa induced macrophages activation via TLR4-MyD88-IKKβ-NF-κB p65 pathways.

Authors:  Lihua Hou; Meng Meng; Yuanyuan Chen; Chunling Wang
Journal:  Oncotarget       Date:  2017-09-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.